LPL Financial
SMMT icon

LPL Financial’s Summit Therapeutics SMMT Stock Holding History

LPL Financial’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$324K Buy
+22,261
New +$395K ﹤0.01% 5381
2026
Q1 		– Sell
-13,160
Closed -$230K – 6144
2025
Q4 		$230K Sell
13,160
-9,633
-42% -$181K ﹤0.01% 5361
2025
Q3 		$471K Sell
22,793
-17,212
-43% -$417K ﹤0.01% 4679
2025
Q2 		$851K Buy
40,005
+26,545
+197% +$605K ﹤0.01% 3899
2025
Q1 		$260K Sell
13,460
-2,626
-16% -$52.7K ﹤0.01% 4676
2024
Q4 		$287K Sell
16,086
-591
-4% -$11.5K ﹤0.01% 4564
2024
Q3 		$365K Buy
+16,677
New +$233K ﹤0.01% 4268

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

LPL Financial's SMMT Position: Q2 2026 in Review

LPL Financial opened a new position in Summit Therapeutics (SMMT) in Q2 2026: 22,261 shares worth $324K. The stake represents ﹤0.01% of the portfolio and ranks #5381 among its holdings. This is a return to the name: LPL Financial previously reported a position in SMMT as recently as Q4 2025.

LPL Financial first reported a position in SMMT in Q3 2024 and has held it in 7 quarters since. The position peaked at $851K in Q2 2025. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • LPL Financial held 22,261 shares of Summit Therapeutics worth $324K as of Q2 2026.
  • Summit Therapeutics was a new LPL Financial position in Q2 2026.
  • Summit Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5381 holding.
  • LPL Financial first reported a position in Summit Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • LPL Financial's Summit Therapeutics position peaked at $851K in Q2 2025.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.